Developing a new device to measure brain chemicals and electrical activity
An Integrated Neurochemical/Electrophysiological Recording and Neuromodulation System for Basic and Clinical Research
['FUNDING_OTHER'] · NAVINETICS NEUROMODULATION, INC. · NIH-11082538
This study is testing a new device called MAVEN that can wirelessly measure important brain chemicals like dopamine and serotonin while also tracking brain activity, which could help doctors better understand and treat brain conditions during surgeries.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | NAVINETICS NEUROMODULATION, INC. (nih funded) |
| Locations | 1 site (ROCHESTER, UNITED STATES) |
| Trial ID | NIH-11082538 on ClinicalTrials.gov |
What this research studies
This research focuses on creating an advanced clinical instrument called MAVEN, which will allow for the wireless measurement of various neurotransmitters in the brain, such as dopamine and serotonin, while also recording electrical activity. The device aims to provide real-time data on both the stimulation-induced and resting levels of these neurochemicals, which is crucial for understanding brain function and disorders. By integrating multiple sensing techniques, MAVEN will enhance the precision and effectiveness of clinical neuroscience research, particularly in brain surgeries. Patients may benefit from improved diagnostic and treatment options as a result of this innovative technology.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals undergoing neurosurgery or those with neurological disorders that affect neurotransmitter levels.
Not a fit: Patients with conditions unrelated to neurotransmitter imbalances or those not undergoing neurosurgical procedures may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better understanding and treatment of neurological conditions through enhanced monitoring of brain chemistry.
How similar studies have performed: Other research has shown promise in using advanced neurochemical sensing techniques, but the MAVEN system represents a novel approach in clinical settings.
Where this research is happening
ROCHESTER, UNITED STATES
- NAVINETICS NEUROMODULATION, INC. — ROCHESTER, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: LEE, KENDALL — NAVINETICS NEUROMODULATION, INC.
- Study coordinator: LEE, KENDALL
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.